Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $4.0952W HIGH $6.71
Volume
164.30 K
Value Traded
667.04 K
Short % Float
2.14%
+2.34%Week
+2.95%1 Month
+3.56%3 Month
-5.76%6 Month
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
393.01 M
EPS (TTM)
-0.01
P/E Ratio
-
Ent. Value
1.46 B
Total Shares
74.01 M
Float Shares
27.20 M
Insiders
63.25%
Institutions
25.52%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
AUNA Catalyst Timeline
Dated clinical, regulatory and corporate events for Auna S.A.
Past FDA Catalysts and PDUFA Decisions
How AUNA actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Auna S.A. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every AUNA program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Zamora Leon JesusDirector, Officer (President) | Buy | 6,420 69,130 held | $4.15 | 05/29/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in AUNA
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| No hedge fund reported a 13F position in AUNA for Q2 2026. | ||||
AUNA Institutional Ownership Trends
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How AUNA ranks across every disease it competes in
Competitive Position is a premium feature
See how AUNA ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialAUNA News
-AUNA
Oct 13, 2026▲ +2.8%today
Auna Announces Reporting Dates for Third Quarter 2026 Financial Results
Auna S.A. has announced the dates for its Third Quarter 2026 financial results. The earnings release is set for November 17, 2026, after market close, followed by a conference call on November 18, 2026, at 8:00 a.m. ET. A quiet period will be observed from November 2 to November 17, 2026.
Read more →-AUNA
Sep 16, 2026Auna to Host 2026 Investor Day on October 22, 2026
Auna, a healthcare platform in Latin America, has announced its first Investor Day scheduled for October 22, 2026. The event will take place in Lima, Peru, and will be accessible both in-person and via a live webcast. This initiative reflects Auna's commitment to engaging with its investors.
Read more →-AUNA
Aug 18, 2026Auna Announces 2Q26 Financial Results
Auna, a prominent healthcare platform in Latin America, has announced its financial results for the second quarter of 2026. The results, expressed in Peruvian Soles, demonstrate the company's adherence to International Financial Reporting Standards. Auna continues to strengthen its presence in Mexico, Peru, and Colombia.
Read more →-AUNA
Jul 20, 2026Auna Announces Reporting Dates for Second Quarter 2026 Financial Results
Auna S.A. has announced the reporting dates for its Second Quarter 2026 financial results. The earnings release is set for August 18, 2026, after market close, followed by a conference call on August 19, 2026, at 8:00 a.m. ET. Auna operates in Mexico, Peru, and Colombia, enhancing its visibility in the healthcare sector.
Read more →-AUNA
May 27, 2026AUNA S.A. Soci t anonyme 6, Rue Jean Monnet L-2180 Luxembourg Grand Duchy of Luxembourg R.C.S. Luxembourg: B267590 (the Company ) Luxembourg
AUNA S.A. has issued a notice for its Annual General Meeting scheduled for June 30, 2026, in Luxembourg. The agenda includes the presentation and approval of various financial statements for the fiscal year 2025, as well as the discharge of directors and auditors. Shareholders who held shares as of May 15, 2026, will be eligible to attend and vote at the meeting. All related financial documents will be available for inspection eight days prior to the meeting.
Read more →-AUNA
May 19, 2026Auna Announces 1Q26 Financial Results
Auna has announced its financial results for the first quarter of 2026. However, the article does not provide specific details about the performance metrics or any significant developments. The lack of information limits the analysis of the company's financial health and future outlook.
Read more →-AUNA
Apr 22, 2026Auna Announces the Filing of Its Form 20 F for the Fiscal Year 2025
Auna S.A. has filed its Annual Report on Form 20-F for the fiscal year ending December 31, 2025, with the SEC. The report is accessible on the SEC's website and Auna's Investor Relations page. Auna continues to expand its healthcare services across Latin America, focusing on prevention and complex diseases.
Read more →-AUNA
Apr 17, 2026Auna Reports Preliminary Key Performance Indicators for the First Quarter ended March 31, 2026
Auna has released preliminary key performance indicators for the first quarter ending March 31, 2026. The report aims to provide insights into the company's performance during this period. However, specific details regarding the indicators have not been disclosed in the article.
Read more →-AUNA
Apr 15, 2026Auna Announces Reporting Dates for First Quarter 2026 Financial Results
Auna has announced the reporting dates for its financial results for the first quarter of 2026. This announcement is part of the company's ongoing communication regarding its financial performance. The specific dates for the reporting have not been detailed in the provided text.
Read more →-AUNA
Mar 10, 2026Auna Announces 4Q25 and FY25 Financial Results Auna Closes FY 2025 with Strong
Auna has announced its financial results for the fourth quarter and full year of 2025, highlighting strong performance in Peru and Colombia with a noteworthy increase in free cash flow. Despite facing challenges in Mexico during 2025, there are clear signs of recovery, with adjusted EBITDA growth anticipated for 2026. The company has made strategic adjustments in management and operations to enhance its market position. Looking forward, Auna projects a 12% revenue growth for 2026, underpinned by efforts to improve cash flow and stabilize its capital structure.
Read more →-AUNA
Feb 26, 2026Auna and EsSalud Finalize Addendum to Commence Construction of Torre Trecca in Lima, Which Will Become Peru s Largest Outpatient Facility
Auna S.A. has finalized an addendum with EsSalud to kick off the construction of Torre Trecca, a significant outpatient healthcare facility in Lima, Peru. The project will cover 59,000 square meters and is expected to boost healthcare capacity in the region by 20%, offering services to more than three million patients annually. Operations are anticipated to start in mid-2028, greatly reducing waiting times for millions of insured Peruvians. This endeavor aligns with Auna's strategy to improve public health services in Latin America.
Read more →-AUNA
Nov 20, 2025Strategic Collaboration with Sojitz to Expand Healthcare Access in Latin America
Auna S.A. has announced a strategic collaboration with Sojitz Corporation of America to explore joint business opportunities in the healthcare sector across Latin America, with a primary focus on Mexico. The partnership is formalized through a Memorandum of Understanding, signaling a commitment to enhance healthcare access in the region. Auna plans to invest around USD 500 million over the next three to five years to expand its integrated healthcare platform. This collaboration aims to leverage Auna's operational expertise and Sojitz's investment capabilities to develop scalable healthcare services.
Read more →-AUNA
Nov 20, 2025Auna Announces 3Q25 Financial Results Auna Delivers Solid Financial and Operating Performance in Peru and Colombia, While Advancing Key Initiatives in Mexico
Auna reported its financial results for Q3 2025, highlighting solid operational performance in Peru and Colombia amid difficult economic conditions. Despite a decline in financial outcomes in Mexico, the company noted improvements in surgical volumes and solid growth from its oncology services. Auna's leadership remains focused on capitalizing on growth opportunities while maintaining a path towards deleveraging. A recent USD765 million debt refinancing is expected to enhance Auna's capital structure.
Read more →-AUNA
Nov 7, 2025Auna Announces Completion of US$765 million Through successful issuance of new Senior Secured
Auna has successfully completed a US$765 million debt refinancing, which includes the issuance of new Senior Secured Notes and a Term Loan. This strategic move extends the company's debt maturities, lowers interest expenses, and improves liquidity, allowing Auna to pursue its growth initiatives in Latin America. The refinancing received strong interest from investors, including a significant contribution from the International Finance Corporation. Auna's management views this as a strong validation of their financial strategy and commitment to enhancing healthcare access across the region.
Read more →-AUNA
Nov 4, 2025AUNA ANNOUNCES SUCCESSFUL PRICING OF 8.750% SENIOR SECURED NOTES DUE 2032 Luxembourg
AUNA S.A. announced the successful pricing of $365 million worth of 8.750% Senior Secured Notes due in 2032. The notes will be co-issued with Oncosalud S.A.C. and will mature on November 6, 2032. Proceeds will be used to fund a tender offer for existing high-interest debt and to prepay other indebtedness. The settlement of the notes is expected to occur on November 6, 2025, pending customary closing conditions.
Read more →-AUNA
Nov 3, 2025▼ -5.4%on this newsshared move
AUNA S.A. ANNOUNCES EARLY RESULTS OF ITS CASH TENDER OFFER AND RELATED CONSENT
AUNA S.A. has announced the early results of its cash tender offer and consent solicitation for its outstanding 10.000% senior secured notes due 2029. As of the early tender date, approximately 73.39% of the notes had been validly tendered, allowing AUNA to obtain the necessary consents for proposed amendments to the indenture governing the notes. The tender offer is set to expire on November 18, 2025, unless extended. Holders of validly tendered notes may receive an early tender payment along with accrued interest, contingent upon the tender offer's successful completion.
Read more →-AUNA
Oct 28, 2025of our report on Form 6-K/A which was furnished to the SEC on
Auna has provided a detailed discussion on its financial condition and operations as part of the Form 6-K/A report submitted to the SEC. The company highlights its commitment to expanding access to healthcare in Latin America while detailing the factors affecting its revenue. Auna also emphasizes its unique operational approach, the 'Auna Way,' which focuses on delivering high-quality, integrated healthcare solutions. However, the company acknowledges the risks associated with forward-looking statements and operational challenges posed by hospital integrations.
Read more →-AUNA
Oct 28, 2025AUNA ANNOUNCES PROPOSED OFFERING OF SENIOR SECURED NOTES DUE 2032
Auna S.A. has announced a proposed offering of senior secured notes due in 2032, aimed at qualified institutional buyers. The proceeds will primarily be used for a tender offer to purchase existing senior secured notes due 2029 and to prepay indebtedness. This move highlights Auna's strategy to optimize its financial structure and strengthen its position within the Latin American healthcare market. Its extensive network includes multiple healthcare facilities and a significant number of health plan members, illustrating its commitment to improving healthcare access in the region.
Read more →About Auna S.A.
BIOPHARMAWATCH ELITE PLUS
Trade the next AUNA catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime